Paul Meisner

4.0k total citations · 2 hit papers
14 papers, 2.7k citations indexed

About

Paul Meisner is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Paul Meisner has authored 14 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Orthopedics and Sports Medicine and 5 papers in Anesthesiology and Pain Medicine. Recurrent topics in Paul Meisner's work include Bone health and osteoporosis research (6 papers), Bone health and treatments (5 papers) and Bone Metabolism and Diseases (5 papers). Paul Meisner is often cited by papers focused on Bone health and osteoporosis research (6 papers), Bone health and treatments (5 papers) and Bone Metabolism and Diseases (5 papers). Paul Meisner collaborates with scholars based in United States, Belgium and Canada. Paul Meisner's co-authors include Judy Maddox, Andreas Grauer, Jeffrey Petersen, Thierry Thomas, Andrew C. Karaplis, Mattias Lorentzon, Maria Luisa Brandi, Kenneth G. Saag, Michelle Fan and E. Michael Lewiecki and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Paul Meisner

13 papers receiving 2.7k citations

Hit Papers

Romosozumab Treatment in Postmenopausal Women with Osteop... 2016 2026 2019 2022 2016 2017 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Romosozumab Treatment in Postmenopausal Women with Osteoporosis
    2016 1.1k citations Felicia Cosman, Daria B. Crittenden et al. New England Journal of Medicine profile →
  2. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
    2017 942 citations Kenneth G. Saag, Jeffrey Petersen et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Meisner United States 11 1.7k 1.4k 1.3k 381 271 14 2.7k
Kaisa K. Ivaska Finland 25 1.1k 0.7× 745 0.5× 655 0.5× 393 1.0× 138 0.5× 65 2.3k
V. Braga Italy 27 1.1k 0.7× 494 0.4× 827 0.6× 315 0.8× 459 1.7× 54 2.1k
Stinus Hansen Denmark 23 1.0k 0.6× 435 0.3× 434 0.3× 397 1.0× 241 0.9× 57 1.8k
A Montagnani Italy 24 817 0.5× 421 0.3× 501 0.4× 310 0.8× 307 1.1× 67 1.6k
Hiromichi Norimatsu Japan 22 1.2k 0.7× 556 0.4× 871 0.7× 551 1.4× 168 0.6× 67 2.3k
Risa Kagan United States 22 1.1k 0.7× 563 0.4× 848 0.6× 276 0.7× 707 2.6× 57 2.3k
G. Luisetto Italy 23 740 0.4× 411 0.3× 410 0.3× 277 0.7× 241 0.9× 74 1.6k
Symeon Tournis Greece 24 639 0.4× 337 0.2× 454 0.3× 289 0.8× 204 0.8× 96 1.8k
John C. Stevenson United Kingdom 22 1.1k 0.7× 434 0.3× 364 0.3× 299 0.8× 531 2.0× 44 2.3k
H.K. Ibbertson New Zealand 23 662 0.4× 441 0.3× 648 0.5× 310 0.8× 211 0.8× 59 2.4k

Countries citing papers authored by Paul Meisner

Since Specialization
Citations

This map shows the geographic impact of Paul Meisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Meisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Meisner more than expected).

Fields of papers citing papers by Paul Meisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Meisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Meisner. The network helps show where Paul Meisner may publish in the future.

Co-authorship network of co-authors of Paul Meisner

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Meisner. A scholar is included among the top collaborators of Paul Meisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Meisner. Paul Meisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Feng, et al.. (2024). Effects of maternal feeding of clofibrate on hepatic fatty acid metabolism in suckling piglet. Journal of Animal Science and Biotechnology. 15(1). 163–163.
2.
McClung, Michael R., Jacques P. Brown, Jean‐Yves Reginster, et al.. (2020). A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab. Osteoporosis International. 31(11). 2231–2241. 35 indexed citations
3.
Cosman, Felicia, Daria B. Crittenden, Serge Ferrari, et al.. (2018). Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome. Journal of Bone and Mineral Research. 33(8). 1407–1416. 56 indexed citations
4.
McClung, Michael R., Jacques P. Brown, Adolfo Díez‐Pérez, et al.. (2018). Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study. Journal of Bone and Mineral Research. 33(8). 1397–1406. 159 indexed citations
5.
Lewiecki, E. Michael, Tomasz Blicharski, Stefan Goemaere, et al.. (2018). A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 103(9). 3183–3193. 201 indexed citations
6.
Saag, Kenneth G., Jeffrey Petersen, Maria Luisa Brandi, et al.. (2017). Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. New England Journal of Medicine. 377(15). 1417–1427. 942 indexed citations breakdown →
7.
Cosman, Felicia, Daria B. Crittenden, Jonathan D. Adachi, et al.. (2016). Romosozumab Treatment in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 375(16). 1532–1543. 1131 indexed citations breakdown →
8.
9.
10.
Steele, Miriam, Howard Steele, Jordan Bate, et al.. (2014). Looking from the outside in: the use of video in attachment-based interventions. Attachment & Human Development. 16(4). 402–415. 55 indexed citations
11.
Rauck, Ryan C., M. Hale, Almasa Bass, et al.. (2014). (410) Efficacy and safety of ALO-02, an extended-release oxycodone surrounding sequestered naltrexone, in the treatment of moderate-to-severe chronic low back pain. Journal of Pain. 15(4). S78–S78. 1 indexed citations
12.
13.
Irizarry, Michael C., David J. Webb, Zahid Ali, et al.. (2009). Predictors of Placebo Response in Pooled Lamotrigine Neuropathic Pain Clinical Trials. Clinical Journal of Pain. 25(6). 469–476. 35 indexed citations
14.
Wallace, Mark S., Michael C. Rowbotham, Rose Dotson, et al.. (2002). A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 59(11). 1694–1700. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaisa K. Ivaska Breakdown of academic impact, for papers by V. Braga Breakdown of academic impact, for papers by Stinus Hansen Breakdown of academic impact, for papers by A Montagnani Breakdown of academic impact, for papers by Hiromichi Norimatsu Breakdown of academic impact, for papers by Risa Kagan Breakdown of academic impact, for papers by G. Luisetto Breakdown of academic impact, for papers by Symeon Tournis Breakdown of academic impact, for papers by John C. Stevenson Breakdown of academic impact, for papers by H.K. Ibbertson
Rankless by CCL
2026